# Immunogenicity of Adjuvanted or Non-adjuvanted H5N1 Booster Vaccine in Adults Primed to A/VN/1194/04

> **NCT00814385** · PHASE1,PHASE2 · COMPLETED · sponsor: **University Hospitals, Leicester** · enrollment: 606 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Aflunov (Single prime, single boost)
- **BIOLOGICAL:** Aflunov (Single prime, single boost)
- **BIOLOGICAL:** Aflunov (single prime, single boost)
- **BIOLOGICAL:** Aflunov (single prime, single boost)
- **BIOLOGICAL:** Aflunov (Double prime, single boost)
- **BIOLOGICAL:** Aflunov (double prime, single boost)
- **BIOLOGICAL:** Aflunov (double prime, single boost)
- **BIOLOGICAL:** Aflunov (double prime, single boost)
- **BIOLOGICAL:** Aflunov (No prime, single boost)

## Key facts

- **NCT ID:** NCT00814385
- **Lead sponsor:** University Hospitals, Leicester
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2013-09
- **Final completion:** 2013-12
- **Target enrollment:** 606 (ACTUAL)
- **Last updated:** 2014-06-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00814385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00814385, "Immunogenicity of Adjuvanted or Non-adjuvanted H5N1 Booster Vaccine in Adults Primed to A/VN/1194/04". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00814385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*